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Introduction
While LVEF is the current most robust marker of mor-
tality in pts with chronic CAD, an improved risk stratifi-
cation method is necessary for guidance of medical or
ICD therapy. Peri-infarct zone (PIZ) as a marker of
infarcted heterogeneity has been associated with arryth-
mogenic substrates and reduced post-MI survival. How-
ever, the prognostic implication of PIZ has not been
studied in a large cohort of CAD pts with long-term fol-
low-up. In addition, whether this prognostic value of
PIZ maintains among different LVEF categories is
unknown.
Purpose
We hypothesized that infarct heterogeneity by CMR
provides strong association with patient mortality
beyond LVEF.
Methods
We studied 404 pts with CAD and a LVEF <60% referred
for CMR. Ten pts (2%) were excluded for non-CAD pat-
tern of late gadolinium enhancement (LGE). The remain-
ing 394 pts (76% males, mean age 60±12 years, mean
LVEF 42±13%) formed the cohort. LGE was performed
10-15 minutes after a total of 0.15-0.2 mmol/kg of Gd-
DTPA. A semi-automatic algorithm quantified the infarct
core and PIZ using SI criteria of >3SD and >2SD above
the remote myocardium, respectively. The PIZ was
expressed as a percentage of the total infarct mass
(%PIZ). All-cause mortality was obtained by medical
record and social security index.
Results
LGE was present in 297 pts (75%). Mean total infarct
mass was 19±23g (14% of LV mass). Mean %PIZ was
19±17%. After a median follow-up of 3.3 years (0.5-
8.2 years), 73 (19%) pts died; with 53 deaths occurred
among the 304 (77%) pts with a LVEF 30-60%. %PIZ
was one of the strongest univariable predictors of mor-
tality (LRc
2=12.63, p=0.0004, Table 1) with the hazard
increased by 25% per 10% %PIZ increase. Adjusting for
age, LVEF, and RVEF, %PIZ maintains a strong associa-
tion with mortality (HR=1.169, LRc
2=4.44, p=0.04). By
forward selection, the best overall model for patient
mortality included %PIZ, age, LVEF, and history of PCI.
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Table 1 Variables significantly associated with all-cause
mortality by univariable analysis
Parameter LR chi-square Hazard ratio p-value
age 16.2 1.05 <0.0001
LVEF 13.45 0.97 0.0002
%PIZ 12.63 1.25 0.0004
Diabetes 12.55 2.30 0.0004
RVEF 10.89 0.97 0.001
LV end-systolic volume index 7.28 1.01 0.007
History of PCI 6.42 0.49 0.0113
LGE 5.06 2.32 0.0246
LV mass index 4.89 1.01 0.027
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robust association with mortality (HR=1.38 per 10%
increase in %PIZ, LRc
2=17, p<0.0001).
Conclusions
In this large observational cohort with long-term follow-
up, infarct heterogeneity measured as %PIZ demonstrated
a strong association with patient mortality, especially in
pts with a LVEF of 30-60%. This association appears
independent of patient age, biventricular systolic function,
and LGE presence. Incorporating CMR infarct heteroge-
neity quantification into the strategic assignment of novel
therapy may be warranted in future clinical trials.
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